U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06924658) titled 'Metformin in Safety and Efficacy in Gouty Patients' on April 05.
Brief Summary: The most frequent crystal arthropathy is gout, which is also the most prevalent cause of inflammatory arthritis. Gouty Patients frequently have excruciating pain and swelling in their joints. Gout is linked to decreased health-related quality of life and functional disability. Gout and its associated diseases have been shown to have a significant impact on patients mortality and morbidities. Metformin, a biguanide, is used to manage diabetes by reducing insulin resistance and preventing comorbidities such as cerebrovascular and coronary artery disease, ...